Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;36(8):1836-1840.
doi: 10.1111/jce.16740. Epub 2025 May 23.

A Modular Approach for Leadless Pacing

Wissam Mekary  1 , Sonya Vijayvargiya  1 , Celine Mouawad  1 , Neal K Bhatia  1 , Anand D Shah  1 , Stacy B Westerman  1 , Michael S Lloyd  1 , Miguel A Leal  1 , Faisal M Merchant  1 , Mikhael F El-Chami  1
Affiliations

A Modular Approach for Leadless Pacing

Wissam Mekary et al. J Cardiovasc Electrophysiol. 2025 Aug.

Abstract

Introduction: The AVEIR leadless pacemaker (LP) is a novel device that can function as a single atrial/ventricular or dual-chamber pacemaker. The introduction of single-chamber atrial LP has allowed electrophysiologists to treat patients with sinus node dysfunction with this device instead of implanting a dual-chamber transvenous pacemaker.

Methods: We retrospectively identified all patients who underwent AVEIR LPs' implantation at Emory Healthcare between 2022 and 2025. Baseline characteristics, indications for pacing, and procedure outcomes were retrieved from electronic medical records. The device's electrical characteristics were reported from routine interrogations done at our device clinic.

Results: Between 2022 and 2025, 89 patients underwent implantation of 37 single-chamber atrial AVEIR, 34 single-chamber ventricular AVEIR, and 18 dual-chamber devices. Patients were followed for a median duration of 4.7 months [2;9]. The rate of major complications was 3.4% and minor complications 1.1%. Two patients with ventricular LP required upgrade to cardiac resynchronization therapy-defibrillator (CRT-D) due to pacing-induced cardiomyopathy (2.3%). One patient (2.7%) with a standalone atrial LP developed atrial fibrillation with slow ventricular response requiring the addition of a ventricular LP 10 months postimplantation.

Conclusion: In our center, we adopted a modular pacing approach for leadless pacing. This strategy focuses on minimizing the amount of hardware in the heart. This reduces complications such as perforation and dislodgment while optimizing battery longevity, which is affected by i2i communication.

Keywords: AVEIR; atrial leadless; leadless pacing; sinus node dysfunction; ventricular leadless.

PubMed Disclaimer

References

    1. E. O. Udo, N. P. A. Zuithoff, N. M. van Hemel, et al., “Incidence and Predictors of Short‐ and Long‐Term Complications in Pacemaker Therapy: The FOLLOWPACE Study,” Heart Rhythm: The Official Journal of the Heart Rhythm Society 9, no. 5 (2012): 728–735.
    1. D. J. Cantillon, S. R. Dukkipati, J. H. Ip, et al., “Comparative Study of Acute and Mid‐Term Complications With Leadless and Transvenous Cardiac Pacemakers,” Heart Rhythm: The Official Journal of the Heart Rhythm Society 15, no. 7 (2018): 1023–1030.
    1. S. Boveda, L. Higuera, C. Longacre, et al., “Two‐Year Outcomes of Leadless vs. Transvenous Single‐Chamber Ventricular Pacemaker in High‐Risk Subgroups,” EP Europace 25, no. 3 (2023): 1041–1050.
    1. G. H. Crossley, J. P. Piccini, C. Longacre, L. Higuera, K. Stromberg, and M. F. El‐Chami, “Leadless Versus Transvenous Single‐Chamber Ventricular Pacemakers: 3 Year Follow‐Up of the Micra CED Study,” Journal of Cardiovascular Electrophysiology 34, no. 4 (2023): 1015–1023.
    1. J. Kakarla and K. Nair, “The Leadless Pacemaker in ACHD—Cautiously Optimistic,” Indian Pacing and Electrophysiology Journal 24, no. 2 (2024): 63–67.

MeSH terms